• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗抑郁药物治疗的持续时间及其对复发风险的影响:不朽且被忽视的时间偏倚。

Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected time bias.

作者信息

Gardarsdottir Helga, Egberts Toine C, Stolker Joost J, Heerdink Eibert R

机构信息

Division of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht University, Utrecht, The Netherlands.

出版信息

Am J Epidemiol. 2009 Aug 1;170(3):280-5. doi: 10.1093/aje/kwp142. Epub 2009 Jun 4.

DOI:10.1093/aje/kwp142
PMID:19498074
Abstract

Several observational studies have found a higher risk of recurrence/relapse of depression for patients who discontinue antidepressant use compared with those who continue. This study demonstrated that measurement of follow-up time can be subject to immortal and neglected time bias. Data were obtained from the 2001 Second Dutch National Survey of General Practice. The study population was composed of antidepressant users with a registered depression diagnosis, divided into early discontinuers and continuing users. Two methods were used to measure time to relapse/recurrence. Method 1, used in previously mentioned studies, measured the beginning of follow-up 6 months after starting antidepressant therapy. Method 2 constructed individual treatment episodes for each patient and measured follow-up from actual end-of-treatment episode. The Cox proportional hazards model produced a risk ratio of 1.58 (95% confidence interval: 1.02, 2.45) for method 1, suggesting a higher risk of relapse/recurrence for early discontinuers. In method 2, a statistically nonsignificant risk ratio of 0.77 (95% confidence interval: 0.49, 1.21) was produced, indicating no difference in risk of relapse/recurrence. The authors found the method used in previous studies subject to bias. Applying a different method, accounting for immortal and neglected time bias, eliminated the protective effects of longer treatments.

摘要

几项观察性研究发现,与持续使用抗抑郁药的患者相比,停药的抑郁症患者复发/再发风险更高。本研究表明,随访时间的测量可能存在永存时间偏倚和失访时间偏倚。数据来自2001年荷兰第二次全科医学全国调查。研究人群由被诊断患有抑郁症的抗抑郁药使用者组成,分为早期停药者和持续使用者。采用两种方法测量复发/再发时间。方法1用于之前提到的研究,在开始抗抑郁治疗6个月后测量随访开始时间。方法2为每位患者构建个体治疗疗程,并从实际治疗疗程结束时开始测量随访。Cox比例风险模型得出方法1的风险比为1.58(95%置信区间:1.02,2.45),表明早期停药者复发/再发风险更高。在方法2中,得出的风险比为0.77(95%置信区间:0.49,1.21),无统计学意义,表明复发/再发风险无差异。作者发现之前研究中使用的方法存在偏倚。采用一种不同的方法,考虑永存时间偏倚和失访时间偏倚,消除了较长疗程的保护作用。

相似文献

1
Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected time bias.抗抑郁药物治疗的持续时间及其对复发风险的影响:不朽且被忽视的时间偏倚。
Am J Epidemiol. 2009 Aug 1;170(3):280-5. doi: 10.1093/aje/kwp142. Epub 2009 Jun 4.
2
The effects of continuous antidepressant treatment during the first 6 months on relapse or recurrence of depression.抗抑郁药治疗最初 6 个月持续治疗对抑郁症复发或再发的影响。
J Affect Disord. 2011 Jul;132(1-2):121-9. doi: 10.1016/j.jad.2011.02.016. Epub 2011 Mar 12.
3
Determinants of antidepressant treatment outcome.抗抑郁治疗效果的决定因素。
Am J Manag Care. 2000 Dec;6(12):1327-36.
4
Confounding by severity and indication in observational studies of antidepressant effectiveness.抗抑郁药疗效观察性研究中严重程度和适应症造成的混杂因素
Can J Clin Pharmacol. 2008 Summer;15(2):e367-71. Epub 2008 Sep 7.
5
One-year outcome with antidepressant--treatment of bipolar depression.抗抑郁药治疗双相抑郁的一年疗效
Acta Psychiatr Scand. 2005 Aug;112(2):105-9. doi: 10.1111/j.1600-0447.2005.00583.x.
6
Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysis.成年双相抑郁症患者停用第二代抗抑郁药与抑郁复发:一项回顾性数据库分析结果
Clin Ther. 2006 Jun;28(6):979-89. doi: 10.1016/j.clinthera.2006.06.011.
7
[Clinical picture and treatment of subsequent depressive episodes--results of Polish multicenter study].[后续抑郁发作的临床表现与治疗——波兰多中心研究结果]
Psychiatr Pol. 2003 May-Jun;37(3):419-31.
8
Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events.基层医疗环境中抗抑郁药的依从性,1:超越疗效不佳和不良事件
J Clin Psychiatry. 2001;62 Suppl 22:30-3.
9
Immortal time bias in pharmaco-epidemiology.药物流行病学中的不朽时间偏倚。
Am J Epidemiol. 2008 Feb 15;167(4):492-9. doi: 10.1093/aje/kwm324. Epub 2007 Dec 3.
10
Long-term follow-up after successful electroconvulsive therapy for depression: a 4- to 8-year naturalistic follow-up study.抑郁症成功接受电休克治疗后的长期随访:一项4至8年的自然随访研究。
J ECT. 2007 Mar;23(1):17-20. doi: 10.1097/01.yct.0000263255.98796.30.

引用本文的文献

1
A systematic review of manipulations to pharmaceutical dosage forms used in psychotropic tapering plans.对用于精神药物减药计划的药物剂型操作的系统评价。
Br J Clin Pharmacol. 2025 Jul;91(7):1899-1913. doi: 10.1002/bcp.70082. Epub 2025 Apr 27.
2
Discontinuation of Antidepressants and the Risk of Medication Resumption among Community-Dwelling Older Adults with Depression in the US.美国社区老年抑郁症患者中断抗抑郁药治疗与重新用药风险。
Int J Environ Res Public Health. 2024 Sep 13;21(9):1209. doi: 10.3390/ijerph21091209.
3
Associations between Pharmacological Treatment Patterns during the Initial Treatment Period and the Relapse or Recurrence of Anxiety Disorders: A Nationwide Retrospective Cohort Study.
初始治疗期药物治疗模式与焦虑症复发或再发之间的关联:一项全国性回顾性队列研究。
Life (Basel). 2023 May 17;13(5):1197. doi: 10.3390/life13051197.
4
May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance.抗抑郁药物会使它们本应治疗的病情恶化吗?耐受性对立模型的临床基础。
Ther Adv Psychopharmacol. 2020 Nov 2;10:2045125320970325. doi: 10.1177/2045125320970325. eCollection 2020.
5
Should we, can we, halt the rise in prescribing for pain and distress?我们应该、能够阻止用于疼痛和痛苦治疗的处方量上升吗?
Br J Gen Pract. 2020 Aug 27;70(698):432-433. doi: 10.3399/bjgp20X712217. Print 2020 Sep.
6
Behavioural activation therapy for depression in adults with non-communicable diseases.针对患有非传染性疾病的成年人抑郁症的行为激活疗法。
Cochrane Database Syst Rev. 2020 Aug 6;8(8):CD013461. doi: 10.1002/14651858.CD013461.pub2.
7
Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations.抑郁和焦虑障碍患者停用抗抑郁药的障碍:文献综述与临床建议
Ther Adv Psychopharmacol. 2020 Jun 10;10:2045125320933404. doi: 10.1177/2045125320933404. eCollection 2020.
8
How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding.从长期来看,抗抑郁药治疗抑郁症的效果如何?对预防复发试验及撤药混淆问题的批判性综述。
Ther Adv Psychopharmacol. 2020 May 8;10:2045125320921694. doi: 10.1177/2045125320921694. eCollection 2020.
9
Methods for constructing treatment episodes and impact on exposure-outcome associations.构建治疗期的方法及其对暴露-结局关联的影响。
Eur J Clin Pharmacol. 2020 Feb;76(2):267-275. doi: 10.1007/s00228-019-02780-4. Epub 2019 Nov 22.
10
Antidepressant Use During Acute Inpatient Care Is Associated With an Increased Risk of Psychiatric Rehospitalisation Over a 12-Month Follow-Up After Discharge.急性住院治疗期间使用抗抑郁药与出院后12个月随访期间精神科再住院风险增加相关。
Front Psychiatry. 2019 Feb 22;10:79. doi: 10.3389/fpsyt.2019.00079. eCollection 2019.